This inventor holds 1 USPTO granted patent. Top assignee: Cipla Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations by Nitin Thakur: A Pioneering Inventor from Mumbai
Introduction
Nitin Thakur, an innovative inventor based in Mumbai, India, has made significant contributions to the field of pharmaceutical sciences. With a specific focus on chemical processes, he holds a patent that showcases his expertise and dedication to advancing medical technologies.
Latest Patents
Nitin Thakur is credited with a patent for an "Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine." This groundbreaking invention relates to a process for effectively separating diastereomers and preparing the compound 9-[(R)-2-[[(R)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine as well as 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine. His work in this area has significant implications for the development of pharmaceutical treatments.
Career Highlights
Nitin Thakur is currently employed at Cipla Limited, a leading global pharmaceutical company known for making healthcare affordable and accessible. His role at Cipla has allowed him to contribute to various innovative projects, further enhancing his career in the pharmaceutical industry.
Collaborations
During his tenure at Cipla Limited, Nitin has collaborated with several talented individuals, including coworkers Dharmaraj Ramachandra Rao and Ashwini Amol Sawant. Their combined efforts exemplify the power of teamwork in fostering innovation and enhancing product development.
Conclusion
Nitin Thakur is an inspiring inventor whose patent contributions reflect his commitment to advancing pharmacy and medicine. As he continues his work at Cipla Limited, his innovations are likely to pave the way for future breakthroughs in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
